Nitrosamine: EMA limits for N-Nitrosomorpholine in drugs

The regulatory authority, in the latest revision “EMA / 409815/2020 Rev.4” of 29 June 2021, added N-nitrosomorpholine (59-89-2) to the list of Nitrosamines to monitor, introducing the maximum limit for this molecule.

Neotron Pharma analytically supports its customers with screening, validation and API-excipient interaction studies.

Learn more

Latest update: 22/07/2021 12:54:09

In the same section